New Minister: Australia's medicines industry yesterday clambered to welcome newly appointed minister Greg Hunt to the health portfolio, with numerous advocacy groups indicating they would soon be knocking on his door.
Reputation: Mainstream media reporting of calls by by Australian researchers for greater transparency around industry funding of patient groups appears to be unaware of MA's work with the Consumers Health Forum.
Leadership: Prime Minister Malcolm Turnbull announces Sussan Ley's departure following receipt of a report into her contentious expenses claims - and also announces sweeping changes to ministerial expenses regulation.
Litigation: A looming class action, whose claims will be heard in early February, could potentially cost Reckitt Benckiser tens of millions of dollars on top of the $6 million fine already secured by the ACCC.
Leadership: Frenchman Herve Gisserot takes on newly-recreated role after shepherding GSK's Chinese operation through a lengthy government pricing investigation which hit the company with a record $542 million fine.
Medicines Safety: A study investigating label information and warnings for four cardiovascular risks in ADHD meds has found that both health professional and consumer labelling provided inconsistent information.
How much damage could Trump do to pharma?
With only a couple of days to go until Donald Trump is inaugurated as the 45th President of the United States, his tendency to bash pharma has many worried. Could he damage the US industry enough to affect Australia?